Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

291 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

Safety and Efficacy of Natalizumab (BG00002, Tysabri®) in Russian Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

NCT02142205

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Belgorod, Russia
  • Research Site Kaluga, Russia
  • Research Site Kazan', Russia
  • Research Site Krasnodar, Russia
View Trial Details
Completed

Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis

NCT00235989

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Los Angeles, California, United States
  • San Francisco, California, United States
  • Washington D.C., District of Columbia, United States
  • Atlanta, Georgia, United States
View all 17 locations
View Trial Details
Completed

A Phase IIa Study of NT-KO-003 for Multiple Sclerosis

NCT01428726

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Charité Universitätsmedizin Berlin, Germany
  • Klinik und Poliklinik für Neurologie Münster, Germany
  • Neurologisches Studienzentrum an der Stiftung Deutsche Klinik für Diagnostik GmbH Wiesbaden, Germany
  • Hospital Germans Trias i Pujol Badalona, Spain
View all 17 locations
View Trial Details
Completed

Autologous T Cell Vaccine (TCV) for Multiple Sclerosis

NCT00245622

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • North Central Neurology Associates, PC Cullman, Alabama, United States
  • Xenoscience - 21st Century Neurology Phoenix, Arizona, United States
  • HOPE Research Institute Phoenix, Arizona, United States
  • Alta Bates Summit Medical Center - East Bay Physicians Medical Group Berkeley, California, United States
View all 33 locations
View Trial Details
Completed

NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness

NCT01591551

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • South Shore Neurologic Associates Patchogue, New York, United States
  • Cornerstone Neurology High Point, North Carolina, United States
  • Providence Brain Institute Portland, Oregon, United States
View Trial Details

Related conditions